Cadence Capital Management’s St Jude Medical STJ Stock Holding History

Cadence Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,734	Closed	-$369K	–	681
2016 Q2	$369K	Buy	4,734 +75	+2%	+$5.35K	0.03%	495
2016 Q1	$256K	Buy	+4,659	New	+$254K	0.02%	572
2014 Q3	–	Sell	-70,160	Closed	-$4.86M	–	621
2014 Q2	$4.86M	Buy	70,160 +17,670	+34%	+$1.15M	0.23%	139
2014 Q1	$3.43M	Buy	+52,490	New	+$3.42M	0.14%	271

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cadence Capital Management's STJ Position: Q3 2016 in Review

Cadence Capital Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 4,734 shares — an estimated $369K sold.

Cadence Capital Management first reported a position in STJ in Q1 2014 and held it in 4 quarters. The position peaked at $4.86M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

Cadence Capital Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
Cadence Capital Management sold 4,734 St Jude Medical shares in Q3 2016, an estimated $369K.
Cadence Capital Management first reported a position in St Jude Medical in Q1 2014 and held it in 4 quarters.
Cadence Capital Management's St Jude Medical position peaked at $4.86M in Q2 2014.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Cadence Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.